HEADER ION TRANSPORT 13-JUN-02 1M0K TITLE BACTERIORHODOPSIN K INTERMEDIATE AT 1.43 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: BACTERIORHODOPSIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BR; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HALOBACTERIUM SALINARUM; SOURCE 3 ORGANISM_TAXID: 2242; SOURCE 4 CELLULAR_LOCATION: PLASMA MEMBRANE; SOURCE 5 EXPRESSION_SYSTEM: HALOBACTERIUM SALINARUM; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 2242; SOURCE 7 EXPRESSION_SYSTEM_CELLULAR_LOCATION: CYTOPLASM; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PRN2367 KEYWDS ION PUMP, MEMBRANE PROTEIN, RETINAL PROTEIN, LIPIDS, PHOTORECEPTOR, KEYWDS 2 HALOARCHAEA, 7-TRANSMEMBRANE, SERPENTINE, MEROHEDRAL TWINNING, ION KEYWDS 3 TRANSPORT EXPDTA X-RAY DIFFRACTION NUMMDL 2 AUTHOR J.K.LANYI REVDAT 4 13-JUL-11 1M0K 1 VERSN REVDAT 3 24-FEB-09 1M0K 1 VERSN REVDAT 2 01-APR-03 1M0K 1 JRNL REVDAT 1 11-SEP-02 1M0K 0 JRNL AUTH B.SCHOBERT,J.CUPP-VICKERY,V.HORNAK,S.SMITH,J.LANYI JRNL TITL CRYSTALLOGRAPHIC STRUCTURE OF THE K INTERMEDIATE OF JRNL TITL 2 BACTERIORHODOPSIN: CONSERVATION OF FREE ENERGY AFTER JRNL TITL 3 PHOTOISOMERIZATION OF THE RETINAL. JRNL REF J.MOL.BIOL. V. 321 715 2002 JRNL REFN ISSN 0022-2836 JRNL PMID 12206785 JRNL DOI 10.1016/S0022-2836(02)00681-2 REMARK 2 REMARK 2 RESOLUTION. 1.43 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.43 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : THIN SHELLS REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.134 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.176 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2090 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 41822 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.127 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.166 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1878 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 35259 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1720 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 330 REMARK 3 SOLVENT ATOMS : 23 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2073.00 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 13 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 8359 REMARK 3 NUMBER OF RESTRAINTS : 8618 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 ANGLE DISTANCES (A) : 0.029 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.025 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.064 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.062 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.008 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: MEROHEDRAL TWINNING RATIO OF 51:49 REMARK 4 REMARK 4 1M0K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-AUG-02. REMARK 100 THE RCSB ID CODE IS RCSB016447. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-AUG-01 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41822 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.430 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.03700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 34.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.43 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.48 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.66400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: SHELX REMARK 200 STARTING MODEL: PDB ENTRY 1C3W REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CUBIC LIPID PHASE WITH MONO-OLEIN AND REMARK 280 POTASSIUM PHOSPHATE, PH 5.60, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 55.57300 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 55.57300 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 55.57300 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE 1 REMARK 300 THIS ENTRY IS MADE UP OF TWO MODELS WHICH REPRESENT REMARK 300 TWO CONFORMATIONS OF THE WILD-TYPE PROTEIN. REMARK 300 MODEL 1 IS THE NON-ILLUMINATED BACTERIORHODOPSIN REMARK 300 (BR STATE) WITH THE OCCUPANCY OF 0.60 WHILE MODEL 2 REMARK 300 IS THE K INTERMEDIATE (K STATE) WITH THE OCCUPANCY OF REMARK 300 0.40. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 24610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -222.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 30.58950 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 52.98257 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -30.58950 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 52.98257 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 1 MET A -12 REMARK 465 1 LEU A -11 REMARK 465 1 GLU A -10 REMARK 465 1 LEU A -9 REMARK 465 1 LEU A -8 REMARK 465 1 PRO A -7 REMARK 465 1 THR A -6 REMARK 465 1 ALA A -5 REMARK 465 1 VAL A -4 REMARK 465 1 GLU A -3 REMARK 465 1 GLY A -2 REMARK 465 1 VAL A -1 REMARK 465 1 SER A 0 REMARK 465 1 GLN A 1 REMARK 465 1 ALA A 2 REMARK 465 1 GLN A 3 REMARK 465 1 ILE A 4 REMARK 465 1 THR A 157 REMARK 465 1 SER A 158 REMARK 465 1 LYS A 159 REMARK 465 1 ALA A 160 REMARK 465 1 GLU A 161 REMARK 465 1 GLU A 232 REMARK 465 1 ALA A 233 REMARK 465 1 GLU A 234 REMARK 465 1 ALA A 235 REMARK 465 1 PRO A 236 REMARK 465 1 GLU A 237 REMARK 465 1 PRO A 238 REMARK 465 1 SER A 239 REMARK 465 1 ALA A 240 REMARK 465 1 GLY A 241 REMARK 465 1 ASP A 242 REMARK 465 1 GLY A 243 REMARK 465 1 ALA A 244 REMARK 465 1 ALA A 245 REMARK 465 1 ALA A 246 REMARK 465 1 THR A 247 REMARK 465 1 SER A 248 REMARK 465 1 ASP A 249 REMARK 465 2 MET A -12 REMARK 465 2 LEU A -11 REMARK 465 2 GLU A -10 REMARK 465 2 LEU A -9 REMARK 465 2 LEU A -8 REMARK 465 2 PRO A -7 REMARK 465 2 THR A -6 REMARK 465 2 ALA A -5 REMARK 465 2 VAL A -4 REMARK 465 2 GLU A -3 REMARK 465 2 GLY A -2 REMARK 465 2 VAL A -1 REMARK 465 2 SER A 0 REMARK 465 2 GLN A 1 REMARK 465 2 ALA A 2 REMARK 465 2 GLN A 3 REMARK 465 2 ILE A 4 REMARK 465 2 THR A 157 REMARK 465 2 SER A 158 REMARK 465 2 LYS A 159 REMARK 465 2 ALA A 160 REMARK 465 2 GLU A 161 REMARK 465 2 GLU A 232 REMARK 465 2 ALA A 233 REMARK 465 2 GLU A 234 REMARK 465 2 ALA A 235 REMARK 465 2 PRO A 236 REMARK 465 2 GLU A 237 REMARK 465 2 PRO A 238 REMARK 465 2 SER A 239 REMARK 465 2 ALA A 240 REMARK 465 2 GLY A 241 REMARK 465 2 ASP A 242 REMARK 465 2 GLY A 243 REMARK 465 2 ALA A 244 REMARK 465 2 ALA A 245 REMARK 465 2 ALA A 246 REMARK 465 2 THR A 247 REMARK 465 2 SER A 248 REMARK 465 2 ASP A 249 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 1 ALA A 98 CA ALA A 98 CB 0.360 REMARK 500 2 ALA A 98 CA ALA A 98 CB 0.541 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 1 ARG A 7 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 1 ARG A 82 NE - CZ - NH1 ANGL. DEV. = -3.8 DEGREES REMARK 500 1 PHE A 135 CB - CG - CD2 ANGL. DEV. = 5.1 DEGREES REMARK 500 1 PHE A 135 CB - CG - CD1 ANGL. DEV. = -6.5 DEGREES REMARK 500 1 TYR A 147 CB - CG - CD1 ANGL. DEV. = -3.9 DEGREES REMARK 500 1 ARG A 175 NE - CZ - NH1 ANGL. DEV. = 6.0 DEGREES REMARK 500 1 ARG A 175 NE - CZ - NH2 ANGL. DEV. = -4.2 DEGREES REMARK 500 2 ARG A 7 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 2 ARG A 82 NE - CZ - NH1 ANGL. DEV. = -3.1 DEGREES REMARK 500 2 PHE A 135 CB - CG - CD2 ANGL. DEV. = 5.1 DEGREES REMARK 500 2 PHE A 135 CB - CG - CD1 ANGL. DEV. = -6.5 DEGREES REMARK 500 2 TYR A 147 CB - CG - CD1 ANGL. DEV. = -3.9 DEGREES REMARK 500 2 ARG A 175 NE - CZ - NH1 ANGL. DEV. = 6.0 DEGREES REMARK 500 2 ARG A 175 NE - CZ - NH2 ANGL. DEV. = -4.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LYS A 216 -64.51 -108.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 1 LI1 A 601 REMARK 610 1 LI1 A 602 REMARK 610 1 LI1 A 603 REMARK 610 1 LI1 A 604 REMARK 610 1 LI1 A 605 REMARK 610 1 LI1 A 606 REMARK 610 1 LI1 A 607 REMARK 610 1 LI1 A 608 REMARK 610 1 LI1 A 609 REMARK 610 1 LI1 A 610 REMARK 610 1 LI1 A 611 REMARK 610 1 LI1 A 612 REMARK 610 1 LI1 A 613 REMARK 610 2 LI1 A 601 REMARK 610 2 LI1 A 602 REMARK 610 2 LI1 A 603 REMARK 610 2 LI1 A 604 REMARK 610 2 LI1 A 605 REMARK 610 2 LI1 A 606 REMARK 610 2 LI1 A 607 REMARK 610 2 LI1 A 608 REMARK 610 2 LI1 A 609 REMARK 610 2 LI1 A 610 REMARK 610 2 LI1 A 611 REMARK 610 2 LI1 A 612 REMARK 610 2 LI1 A 613 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RET A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 605 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 606 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 607 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 608 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 609 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 610 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 611 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 612 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 613 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SQU A 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1M0L RELATED DB: PDB REMARK 900 BACTERIORHODOPSIN/LIPID COMPLEX AT 1.47 A RESOLUTION REMARK 900 RELATED ID: 1M0M RELATED DB: PDB REMARK 900 BACTERIORHODOPSIN M1 INTERMEDIATE AT 1.43 A RESOLUTION DBREF 1M0K A -12 249 UNP P02945 BACR_HALN1 1 262 SEQRES 1 A 262 MET LEU GLU LEU LEU PRO THR ALA VAL GLU GLY VAL SER SEQRES 2 A 262 GLN ALA GLN ILE THR GLY ARG PRO GLU TRP ILE TRP LEU SEQRES 3 A 262 ALA LEU GLY THR ALA LEU MET GLY LEU GLY THR LEU TYR SEQRES 4 A 262 PHE LEU VAL LYS GLY MET GLY VAL SER ASP PRO ASP ALA SEQRES 5 A 262 LYS LYS PHE TYR ALA ILE THR THR LEU VAL PRO ALA ILE SEQRES 6 A 262 ALA PHE THR MET TYR LEU SER MET LEU LEU GLY TYR GLY SEQRES 7 A 262 LEU THR MET VAL PRO PHE GLY GLY GLU GLN ASN PRO ILE SEQRES 8 A 262 TYR TRP ALA ARG TYR ALA ASP TRP LEU PHE THR THR PRO SEQRES 9 A 262 LEU LEU LEU LEU ASP LEU ALA LEU LEU VAL ASP ALA ASP SEQRES 10 A 262 GLN GLY THR ILE LEU ALA LEU VAL GLY ALA ASP GLY ILE SEQRES 11 A 262 MET ILE GLY THR GLY LEU VAL GLY ALA LEU THR LYS VAL SEQRES 12 A 262 TYR SER TYR ARG PHE VAL TRP TRP ALA ILE SER THR ALA SEQRES 13 A 262 ALA MET LEU TYR ILE LEU TYR VAL LEU PHE PHE GLY PHE SEQRES 14 A 262 THR SER LYS ALA GLU SER MET ARG PRO GLU VAL ALA SER SEQRES 15 A 262 THR PHE LYS VAL LEU ARG ASN VAL THR VAL VAL LEU TRP SEQRES 16 A 262 SER ALA TYR PRO VAL VAL TRP LEU ILE GLY SER GLU GLY SEQRES 17 A 262 ALA GLY ILE VAL PRO LEU ASN ILE GLU THR LEU LEU PHE SEQRES 18 A 262 MET VAL LEU ASP VAL SER ALA LYS VAL GLY PHE GLY LEU SEQRES 19 A 262 ILE LEU LEU ARG SER ARG ALA ILE PHE GLY GLU ALA GLU SEQRES 20 A 262 ALA PRO GLU PRO SER ALA GLY ASP GLY ALA ALA ALA THR SEQRES 21 A 262 SER ASP HET RET A 301 20 HET LI1 A 601 32 HET LI1 A 602 41 HET LI1 A 603 18 HET LI1 A 604 16 HET LI1 A 605 8 HET LI1 A 606 8 HET LI1 A 607 38 HET LI1 A 608 18 HET LI1 A 609 16 HET LI1 A 610 40 HET LI1 A 611 17 HET LI1 A 612 18 HET LI1 A 613 13 HET SQU A 701 27 HETNAM RET RETINAL HETNAM LI1 1-[2,6,10.14-TETRAMETHYL-HEXADECAN-16-YL]-2-[2,10,14- HETNAM 2 LI1 TRIMETHYLHEXADECAN-16-YL]GLYCEROL HETNAM SQU 2,10,23-TRIMETHYL-TETRACOSANE HETSYN LI1 LIPID FRAGMENT HETSYN SQU LIPID FRAGMENT FORMUL 2 RET C20 H28 O FORMUL 3 LI1 13(C42 H86 O3) FORMUL 16 SQU C27 H56 FORMUL 17 HOH *23(H2 O) HELIX 1 1 GLU A 9 GLY A 31 1 23 HELIX 2 2 ASP A 36 LEU A 62 1 27 HELIX 3 3 TRP A 80 VAL A 101 1 22 HELIX 4 4 ASP A 104 THR A 128 1 25 HELIX 5 5 VAL A 130 GLY A 155 1 26 HELIX 6 6 ARG A 164 GLY A 192 1 29 HELIX 7 7 PRO A 200 SER A 226 1 27 HELIX 8 8 ARG A 227 PHE A 230 5 4 SHEET 1 A 2 THR A 67 PHE A 71 0 SHEET 2 A 2 GLU A 74 ILE A 78 -1 O ILE A 78 N THR A 67 LINK C15 RET A 301 NZ LYS A 216 1555 1555 1.32 SITE 1 AC1 11 TRP A 86 THR A 90 MET A 118 SER A 141 SITE 2 AC1 11 THR A 142 TRP A 182 TYR A 185 PRO A 186 SITE 3 AC1 11 TRP A 189 ASP A 212 LYS A 216 SITE 1 AC2 5 ILE A 11 ILE A 140 LI1 A 606 LI1 A 608 SITE 2 AC2 5 SQU A 701 SITE 1 AC3 10 TRP A 12 TYR A 131 PHE A 135 VAL A 136 SITE 2 AC3 10 ASN A 202 ILE A 203 LEU A 206 LEU A 207 SITE 3 AC3 10 LI1 A 603 LI1 A 608 SITE 1 AC4 4 LEU A 190 ILE A 198 LI1 A 602 LI1 A 604 SITE 1 AC5 2 ILE A 198 LI1 A 603 SITE 1 AC6 2 LI1 A 606 LI1 A 611 SITE 1 AC7 5 ALA A 18 LEU A 22 LI1 A 601 LI1 A 605 SITE 2 AC7 5 LI1 A 611 SITE 1 AC8 7 THR A 55 MET A 56 TYR A 64 TRP A 80 SITE 2 AC8 7 PHE A 88 GLY A 116 LEU A 127 SITE 1 AC9 3 LI1 A 601 LI1 A 602 SQU A 701 SITE 1 BC1 4 PHE A 154 ASN A 176 VAL A 180 LI1 A 610 SITE 1 BC2 7 PHE A 153 LYS A 172 ASN A 176 VAL A 180 SITE 2 BC2 7 SER A 183 VAL A 187 LI1 A 609 SITE 1 BC3 4 LEU A 22 TYR A 26 LI1 A 605 LI1 A 606 SITE 1 BC4 9 THR A 24 LEU A 25 LEU A 28 TYR A 43 SITE 2 BC4 9 ALA A 44 THR A 47 ALA A 110 TYR A 147 SITE 3 BC4 9 HOH A 512 SITE 1 BC5 1 LEU A 87 SITE 1 BC6 7 VAL A 213 SER A 214 VAL A 217 GLY A 218 SITE 2 BC6 7 LEU A 221 LI1 A 601 LI1 A 608 CRYST1 61.179 61.179 111.146 90.00 90.00 120.00 P 63 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016345 0.009437 0.000000 0.00000 SCALE2 0.000000 0.018874 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008997 0.00000 MODEL 1